Invention Grant
- Patent Title: Delivery and formulation of engineered nucleic acids
-
Application No.: US15379284Application Date: 2016-12-14
-
Publication No.: US09950068B2Publication Date: 2018-04-24
- Inventor: Antonin De Fougerolles , Sayda M. Elbashir
- Applicant: ModernaTX, Inc.
- Applicant Address: US MA Cambridge
- Assignee: ModernaTX, Inc.
- Current Assignee: ModernaTX, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Clark & Elbing LLP
- Main IPC: A61K31/7088
- IPC: A61K31/7088 ; A61K31/7115 ; C07K14/535 ; C12N15/87 ; C12N9/64 ; A61K47/18 ; A61K38/48 ; A61K47/22 ; A61K47/28 ; A61K38/19 ; A61K48/00
Abstract:
Provided are formulations, compositions and methods for delivering biological moieties such as modified nucleic acids into cells to modulate protein expression. Such compositions and methods include the delivery of biological moieties, and are useful for production of proteins.
Public/Granted literature
- US20170258915A1 Delivery and Formulation of Engineered Nucleic Acids Public/Granted day:2017-09-14
Information query
